1-3 of 3
Anthony R. Green, FRCP, FRCPath, FMed Sci
Close
Sort by
Journal Articles

Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial

Anna L. Godfrey, BMBCh, PhD MRCP, FRCPath, Peter J Campbell, MD PhD, Cathy MacLean, BSc, MSc, MBA, Georgina Buck, BSc, MSc, Clare L. East, BSc, Julia Cook, BSc, Julie Temple, BSc, Bridget S. Wilkins, MD FRCPath, Keith Wheatley, DPhil, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Mary Frances Frances McMullin, MB,Bch BAO, MD FRCPath, Cecily Forsyth, MB BS, Jean-Jacques Kiladjian, MD PhD, Anthony R. Green, FRCP, FRCPath, FMed Sci, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 319.
https://doi.org/10.1182/blood.V130.Suppl_1.319.319
Published: 2017
Journal Articles

Physiological Levels of Jak2 V617F Result in Enhanced Megakaryocyte Differentiation, Proplatelet Formation and Platelet Reactivity.

Cedric J Ghevaert, MD, PhD, Juan Li, PhD, Sonia Severin, PhD, Jocelyn Auger, PhD, Steve Watson, BSc, PhD, Anthony R. Green, FRCP, FRCPath, FMed, Sci
Journal: Blood
Blood (2009) 114 (22): 226.
https://doi.org/10.1182/blood.V114.22.226.226
Published: 2009
Journal Articles

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Nicholas C.P. Cross, PhD, FRCPath, Peter Campbell, MD, PhD, Philip A Beer, BM, MRCP, MRCPath, Susanne Schnittger, PhD, Alessandro M. Vannucchi, MD, Katerina Zoi, PhD, Melanie Percy, PhD, FRCPath, Mary Frances McMullin, Linda Scott, BSc, PhD, Richard T. Silver, MD, David Oscier, MD, Claire Harrison, MD, Anthony R. Green, FRCP, FRCPath, FMed, Sci, Andrew Chase, PhD
Journal: Blood
Blood (2009) 114 (22): 433.
https://doi.org/10.1182/blood.V114.22.433.433
Published: 2009